Sudhir Agrawal is founder of ARNAY Sciences LLC. He is also serving as visiting professor in the department of medicine at University of Massachusetts Medical School, and a member of the business advisory board of Harvard Medical School’s Initiative for RNA Medicine. He is currently serving as a member of the scientific advisory boards of several biotechnology companies. He is also a founder of Idera Pharmaceuticals and has had held various leadership roles within the company, including Chairman, CEO, President of Research, and Chief Scientific Officer until 2017. Over the last three decades, his research has been focused on the discovery and development of RNA therapeutics. He has published over 300 research papers and is listed as a co-inventor of more than 400 patents worldwide. He has edited four books on oligonucleotides and antisense technology, including a recent book on ‘Advances in Nucleic Acid Therapeutics’ published in February 2019 by The Royal Society of Chemistry.
Please consider donating. Every dollar donated goes toward keeping our research alive.
The Dan Lewis Foundation for Brain Regeneration Research is an incorporated 501(c)(3) non-profit organization. Donations are tax deductible.
Thank you to our sponsors: Google for Non-Profits | The Helton Family Foundation | The Center for Professional Innovation & Education, Inc. | Caliber Home Loans
Donations of stock may have significant tax benefits for the donor and are a great way to support the foundation. Please contact us for more information regarding the tax benefits and the process of transferring stock to the foundation.
All Rights Reserved | The Dan Lewis Foundation For Brain Regeneration Research | In Partnership With CCC